Sebastian J Wallace1, Rachael Swann2, Mhairi Donnelly3, Linda Kemp4, Julia Guaci3, Aimee Murray2, Johannes Spoor2, Nan Lin5, Michael Miller4, Harry R Dalton6, S Hyder Hussaini6, Rory Gunson7, Kenneth Simpson3, Adrian Stanley2, Andrew Fraser2,3. 1. Department of Gastroenterology, Aberdeen Royal Infirmary, Aberdeen, UK. 2. Department of Gastroenterology, NHS Greater Glasgow and Clyde, Glasgow, UK. 3. Department of Gastroenterology, Royal Infirmary Edinburgh, Edinburgh, UK. 4. Department of Gastroenterology, Ninewells Hospital, Dundee, UK. 5. Department of Mathematics, Physics and Electrical Engineering, Northumbria University, Newcastle, UK. 6. Department of Gastroenterology, Royal Cornwall Hospital Trust, Truro, Cornwall, UK. 7. Department of Virology, NHS Greater Glasgow and Clyde, Glasgow, UK.
Abstract
BACKGROUND: Hepatitis E virus (HEV) is the most common acute viral hepatitis in Scotland. Little is known about the burden of morbidity and mortality, which can be high in chronic liver disease or immunocompromised states. AIMS: To record the morbidity and mortality of HEV in Scotland. METHODS: Demographic, clinical and laboratory data were collected retrospectively from all cases of HEV reported to virology departments across nine NHS health boards, between January 2013 and January 2018. RESULTS: Five hundred and eleven cases were included (Mean age 62, 64% male). 58 (11%) cases had pre-existing cirrhosis and 110 (21%) had diabetes. Three hundred and three patients required admission (59%), totalling 2747 inpatient bed days. Seventeen (3.3%) HEV-related deaths were recorded. Factors that predicted mortality included haematological malignancy (OR 51.56, 95% CI 3.40-782.83, P = 0.005), cirrhosis (OR 41.85, 95% CI 2.85-594.16, P = 0.006), higher serum bilirubin (OR 1.01, 95% CI 1.01-1.02, P = 0.011) and chronic HEV infection (OR 0.02, 95% CI 0.02-0.28, P < 0.001). HEV infection affected 35 transplant patients of 106 total immunosuppressed patients (21%). Of these, 25 patients received Ribavirin therapy with a sustained virological remission of 76%. Thirty-five (6.7%) patients developed acute or acute-on-chronic liver failure with two requiring transplant. Thirty-seven (7.2%) patients reported neurological complications with 10 developing neuralgic amyotrophy, 6 Guillain-Barré and 2 encephalitis. Forty-four (8.6%) patients developed acute kidney injury. CONCLUSION: In Scotland, HEV causes a significant burden of inpatient admissions, organ failure and death. Cirrhosis and haematological malignancy are significant predictors of mortality. Neurological and renal complications occur in a significant minority.
BACKGROUND:Hepatitis E virus (HEV) is the most common acute viral hepatitis in Scotland. Little is known about the burden of morbidity and mortality, which can be high in chronic liver disease or immunocompromised states. AIMS: To record the morbidity and mortality of HEV in Scotland. METHODS: Demographic, clinical and laboratory data were collected retrospectively from all cases of HEV reported to virology departments across nine NHS health boards, between January 2013 and January 2018. RESULTS: Five hundred and eleven cases were included (Mean age 62, 64% male). 58 (11%) cases had pre-existing cirrhosis and 110 (21%) had diabetes. Three hundred and three patients required admission (59%), totalling 2747 inpatient bed days. Seventeen (3.3%) HEV-related deaths were recorded. Factors that predicted mortality included haematological malignancy (OR 51.56, 95% CI 3.40-782.83, P = 0.005), cirrhosis (OR 41.85, 95% CI 2.85-594.16, P = 0.006), higher serum bilirubin (OR 1.01, 95% CI 1.01-1.02, P = 0.011) and chronic HEVinfection (OR 0.02, 95% CI 0.02-0.28, P < 0.001). HEVinfection affected 35 transplant patients of 106 total immunosuppressed patients (21%). Of these, 25 patients received Ribavirin therapy with a sustained virological remission of 76%. Thirty-five (6.7%) patients developed acute or acute-on-chronic liver failure with two requiring transplant. Thirty-seven (7.2%) patients reported neurological complications with 10 developing neuralgic amyotrophy, 6 Guillain-Barré and 2 encephalitis. Forty-four (8.6%) patients developed acute kidney injury. CONCLUSION: In Scotland, HEV causes a significant burden of inpatient admissions, organ failure and death. Cirrhosis and haematological malignancy are significant predictors of mortality. Neurological and renal complications occur in a significant minority.
Authors: Robert John Fontana; Ronald E Engle; Paul H Hayashi; Jiezhun Gu; David E Kleiner; Hahn Nguyen; Huiman Barnhart; Jay H Hoofnagle; Patrizia Farci Journal: Am J Gastroenterol Date: 2022-06-10 Impact factor: 12.045
Authors: Patricia Momoyo Yoshimura Zitelli; Michele Gomes-Gouvêa; Daniel F Mazo; Julio da Motta Singer; Claudia P M S Oliveira; Alberto Queiroz Farias; João Renato Pinho; Ryan Yukimatsu Tanigawa; Venâncio Avancini Ferreira Alves; Flair José Carrilho; Mário Guimarães Pessoa Journal: Clinics (Sao Paulo) Date: 2021-11-26 Impact factor: 2.365
Authors: Christophe Masset; Paul Le Turnier; Céline Bressollette-Bodin; Karine Renaudin; François Raffi; Jacques Dantal Journal: Int J Mol Sci Date: 2022-10-10 Impact factor: 6.208
Authors: Robert J Fontana; Ronald E Engle; Michelle Gottfried; Bilal Hammed; James Hanje; Valerie Durkalski; David E Kleiner; Hanh Nguyen; Norihisa Nishimura; William M Lee; Patrizia Farci Journal: Clin Transl Gastroenterol Date: 2020-11 Impact factor: 4.396